Halozyme Therapeutics

Aktienkurs
69.53
Täglich Wechseln
0.31 0.45%
Monatlich
-4.53%
Jährlich
17.55%
Q1 Prognose
67.38




Ebit Veränderung Datum
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amarin USD -1.7M 8.47M 2025-09
Amgen USD 3.96B 464M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Cara Therapeutics USD -2.39M 3.16M 2025-03
Cytokinetics USD -178.37M 11.61M 2025-12
DBV Technologies USD -34.28M 6.83M 2025-09
Eli Lilly USD 8.99B 1.57B 2025-12
Esperion Therapeutics USD -16.03M 11.51M 2024-09
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Intrexon USD -26.3M 2.91M 2024-06
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
MannKind USD -69.24M 28.19M 2025-12
Minerva Neurosciences USD -4.37M 1.71M 2024-09
Nektar Therapeutics USD -34.34M 3.68M 2024-09
Pfizer USD 4.65B 71M 2025-12
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
United Therapeutics USD -14.6M 403.9M 2025-12
Vanda Pharmaceuticals USD -10.28M 721K 2024-12


Halozyme Therapeutics - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.